Hemagglutinin Inhibitors are Potential Future Anti-Influenza Drugs for Mono- and Combination Therapies
- 19 April 2020
- book chapter
- Published by Springer Nature
- Vol. 2132, 547-565
Abstract
Infections by H1-H16 influenza A viruses require sufficient binding of viral hemagglutinins (HAs) to specific target receptors, glycoconjugates bearing sialyl sugar chains, on the host cell surface. Synthesized sialyl sugar chains targeting sialyl sugar-binding sites in HAs that are immutable as long as the virus does not switch to a different host species might therefore be highly effective candidate drugs for inhibition of the initial required step of virus entry. In this chapter, we describe the following aspects of updated sialyl sugar chains as influenza A virus HA inhibitors (HAIs): (1) mode of terminal sialyl-galactose linkage, (2) molecular length and structure of sialyl glycan receptors, (3) multivalent sialyl sugar chain dimension, (4) clustering of sialyl sugar chains on macromolecular scaffolds, and (5) enhancement of the stability of sialyl sugar chain HA inhibitors. We also discuss about the use of HAI-based combinations that should be considered for future influenza therapy.Keywords
This publication has 42 references indexed in Scilit:
- The specificity of the influenza B virus hemagglutinin receptor binding pocket: what does it bind to?Journal of Molecular Recognition, 2013
- Glycomic Analysis of Human Respiratory Tract Tissues and Correlation with Influenza Virus InfectionPLOS Pathogens, 2013
- Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferretsNature, 2012
- Antiviral effects of Psidium guajava Linn. (guava) tea on the growth of clinical isolated H1N1 viruses: Its role in viral hemagglutination and neuraminidase inhibitionAntiviral Research, 2012
- A Highly Conserved Neutralizing Epitope on Group 2 Influenza A VirusesScience, 2011
- Chemoenzymatic synthesis, characterization, and application of glycopolymers carrying lactosamine repeats as entry inhibitors against influenza virus infectionGlycobiology, 2008
- Chemoenzymatic synthesis of artificial glycopolypeptides containing multivalent sialyloligosaccharides with a γ-polyglutamic acid backbone and their effect on inhibition of infection by influenza virusesBioorganic & Medicinal Chemistry, 2007
- Glycan microarray technologies: tools to survey host specificity of influenza virusesNature Reviews Microbiology, 2006
- Glycotentacles: Synthesis of Cyclic Glycopeptides, Toward a Tailored Blocker of Influenza Virus HemagglutininAngewandte Chemie International Edition, 2003
- Chemoenzymatic synthesis and application of glycopolymers containing multivalent sialyloligosaccharides with a poly(L-glutamic acid) backbone for inhibition of infection by influenza virusesGlycobiology, 2002